DirectorsTalk LSE Stock market news, financial, press release, articles and interviews 
AVO’s goal is to deliver an affordable and novel proton therapy (PT) system, called LIGHT, based on state-of-the-art technology developed originally at the world-renowned CERN. Over the past two years, ...
Read Article »Home » Hardman Research
Hardman Research
-
B-North: Bridge over troubled waters
-
Incanthera preparing Sol for commercialisation
-
Anglo Asian Mining Small-cap gold miner with bigger-cap prospects
-
City of London Investment Group Karpus transaction looks a winner
-
Burford Capital Putting fears to rest
-
Filta Group FY’19 results and COVID-19 update
-
Real Estate Credit Investments Getting a balanced view on outlook
-
Arix Bioscience 1Q’20 portfolio update
-
Phoenix Copper Ltd Potential world-class copper-gold-silver mine
-
Artificial Solutions Conversational artificial intelligence made real
-
City of London Investment Group Handling challenging markets well
-
Arix Bioscience Resetting the stage
-
Surface Transforms High visibility for 2021 onwards; equity raise
-
UK Housebuilding Sector in 1Q 2020
-
Arbuthnot Banking Group Plc 2019 results: resilience into the storm
-
Diurnal Group $52.5m US deal strengthens balance sheet further
-
Chamberlin Trading stalled in these unprecedented times
-
Arix Bioscience Fiscal 2019 – moving with the times
-
RM Secured Direct Lending Manager presentation at the Hardman & Co Investor Forum
-
B-North Taking the next steps forward
-
Haydale Graphene Industries Cost savings continue, revenue growth encouraging
-
Allergy Therapeutics plc Consistent first-half revenue growth
-
Pantheon International Plc 2020 interim results: consistency in delivery
-
Primary Health Properties Final results show accelerating rental growth
-
Diurnal Group … and more to come (news flow)
-
Burford Capital Mixture of strong and weak activity in 2019
-
Titon Holdings Condititoning
-
City of London Investment Group Interim results validate good first half performance
-
Arix Bioscience With high risk can come high reward
-
Neodecortech Well placed for 2020
-
Advanced Oncotherapy Confidence in LIGHT gaining momentum
-
Chamberlin Plc Near-term trading subdued
-
Resource upgrade and happy strategic dilemma
-
Tissue Regenix Restructured to satisfy product demand
-
Genedrive Plc Western market progress but developing markets difficult
-
Volta Finance Follow the money
-
Shield Therapeutics Plc Good demand for Feraccru in Europe
-
Non-Standard Finance Sunshine after the rain
-
Allergy Therapeutics Sales growth well above market average
-
Morses Club Value-added, customer-driven expansion from core
